Archive · 2 Aug 2025
Artificial Sweetener Sucralose May Impair Cancer Treatment
Researchers found that sucralose, a common artificial sweetener, could make some cancer treatments less effective.
They tested this on mice and discovered that sucralose changes the bacteria in the gut, which lowers levels of a nutrient called arginine.
This change seems to stop some treatments from working well, especially for immunotherapy.
However, the study also showed that giving arginine supplements might help fix this issue.
This is important because many people with cancer use sucralose, and changing their diet can be difficult.
More research is needed to see if this applies to people.
Sucralose, an artificial sweetener, may interfere with cancer treatments.
Research suggests that sucralose use may worsen survival rates for some cancer patients.
The study indicates that sucralose disrupts gut bacteria, reducing arginine levels.
Lower arginine levels due to sucralose can hinder immunotherapy effectiveness.
Arginine supplements may counteract sucralose's negative impacts on treatments.
- Who
- Researchers, cancer patients, and individuals using sucralose.
- What
- Sucralose may interfere with cancer treatments.
- When
- The research was recently conducted and published.
- Where
- University of Pittsburgh and UPMC Hillman Cancer Centre.
- Why
- To understand how sucralose impacts cancer treatment effectiveness.
Potential Negative Effects
Potential Countermeasures
Impact on Treatment
Potential Negative Effects
Sucralose use may worsen the effectiveness of cancer treatments and survival rates.
Potential Countermeasures
Arginine supplements might counteract the negative effects of sucralose on cancer treatment.
- Artificial Sweetener
- Sucralose
- Study Locations
- University of Pittsburgh, UPMC Hillman Cancer Centre
- Cancer Types Mentioned
- Melanoma, non-small cell lung cancer
- Effect on Mice
- Disrupted gut bacteria
- Potential Solution
- Arginine supplements